Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 21

Trial Status

Completed2
Terminated1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT00948753Phase 1/2Completed
Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation
Graft-versus-host DiseaseHematopoietic Stem Cell Transplantation
PrincipalinvestigatorStart date: 2009-06-01
NCT00674427Phase 1Terminated
Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaChronic Lymphocytic Leukemia+5 more
Principalinvestigator
NCT00891592Phase 1Completed
Umbilical Cord Blood Transplant for Hematological Malignancies
ALLAMLCML+4 more
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Elizabeth Hexner, MD

University of Pennsylvania

Very Similar
1 trials

Shared therapeutic areas:

ALLAmlCML+4 more

Worked with same sponsors:

University of Pennsylvania
Collaborated on 1 trial
Similarity Score74%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft vs Host Disease+6 more
Similarity Score18%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Graft vs Host DiseaseHodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-Lymphoma+6 more
Similarity Score18%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Hodgkin DiseaseMultiple MyelomaLymphoma, Non-Hodgkin+5 more
Similarity Score16%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myeloid, AcuteHodgkin Disease+3 more
Similarity Score12%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteAmlGraft vs Host Disease+2 more
Similarity Score10%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteMyelodysplastic Syndromes+2 more
Similarity Score10%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell+2 more
Similarity Score10%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

Myelodysplastic SyndromesLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma+2 more
Similarity Score10%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic Syndromes+1 more
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00948753Phase 1/2PrincipalInvestigator

Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation

Graft-versus-host DiseaseHematopoietic Stem Cell Transplantation
Completed
NCT00674427Phase 1PrincipalInvestigator

Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant

Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaChronic Lymphocytic Leukemia+5 more
Terminated
NCT00891592Phase 1PrincipalInvestigator

Umbilical Cord Blood Transplant for Hematological Malignancies

ALLAMLCML+4 more
Completed

All 3 trials loaded